Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elad Sharon

Showing results (1-10 of 191) with videos related to

Pageof 20
Sort By:
Clinical Trials (London, England)|March 28, 2017
Commentary on Perez et al.: How to create a 21st century adverse event reporting systemElad Sharon
Seminars in Perinatology|March 15, 2025
Immune checkpoint inhibitors and pregnancy: Considerations for treating medically complex patients with the best available therapyElad Sharon
JAMA Oncology|March 7, 2024
Advancing Truth in Oncology by Complementing Clinical Trials With Evidence From Clinical PracticeElad Sharon
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2017
Can an Immune Checkpoint Inhibitor (Sometimes) Make Things Worse?Elad Sharon
The New England Journal of Medicine|January 11, 2013
Fibulin-3 as a biomarker for pleural mesotheliomaKevin Hollevoet, Elad Sharon
Journal of the American College of Cardiology|October 29, 2021
From Detecting Signals to Understanding Cardiovascular Toxicities of Cancer Therapies: All the Light We Could SeeAna Barac, Elad Sharon
Cancer Immunology Research|April 5, 2017
Report on the FDA-AACR Immuno-oncology Drug Development WorkshopColleen Curran, Elad Sharon
Chinese Journal of Cancer|April 23, 2013
IGF-1R as an anti-cancer target--trials and tribulationsHelen X Chen, Elad Sharon
Journal of the National Cancer Institute|March 21, 2023
Design of phase II oncology trials evaluating combinations of experimental agentsElad Sharon, Jared C Foster
Future Oncology (London, England)|March 28, 2006
The future of cancer prevention: ripe for a revolutionElad Sharon, Fadlo R Khuri
Pageof 20

Showing results (1-10 of 191) with videos related to

Sort By:
Pageof 20
Clinical Trials (London, England)|March 28, 2017
Commentary on Perez et al.: How to create a 21st century adverse event reporting systemElad Sharon
Seminars in Perinatology|March 15, 2025
Immune checkpoint inhibitors and pregnancy: Considerations for treating medically complex patients with the best available therapyElad Sharon
JAMA Oncology|March 7, 2024
Advancing Truth in Oncology by Complementing Clinical Trials With Evidence From Clinical PracticeElad Sharon
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2017
Can an Immune Checkpoint Inhibitor (Sometimes) Make Things Worse?Elad Sharon
The New England Journal of Medicine|January 11, 2013
Fibulin-3 as a biomarker for pleural mesotheliomaKevin Hollevoet, Elad Sharon
Journal of the American College of Cardiology|October 29, 2021
From Detecting Signals to Understanding Cardiovascular Toxicities of Cancer Therapies: All the Light We Could SeeAna Barac, Elad Sharon
Cancer Immunology Research|April 5, 2017
Report on the FDA-AACR Immuno-oncology Drug Development WorkshopColleen Curran, Elad Sharon
Chinese Journal of Cancer|April 23, 2013
IGF-1R as an anti-cancer target--trials and tribulationsHelen X Chen, Elad Sharon
Journal of the National Cancer Institute|March 21, 2023
Design of phase II oncology trials evaluating combinations of experimental agentsElad Sharon, Jared C Foster
Future Oncology (London, England)|March 28, 2006
The future of cancer prevention: ripe for a revolutionElad Sharon, Fadlo R Khuri
Pageof 20